Company Filing History:
Years Active: 2014-2020
Title: Innovator Spotlight: Markus Follman
Introduction: Markus Follman, based in Köln, Germany, is an accomplished inventor with a focus on innovative solutions in the pharmaceutical field. With two patents to his name, he is making significant contributions to the treatment of cardiovascular disorders through his research and development efforts.
Latest Patents: Markus Follman holds two notable patents. The first patent is for "Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their use." This patent pertains to novel substituted imidazo[1,2-a]pyridine-3-carboxamides and outlines processes for their preparation and their potential use in treating various diseases, particularly cardiovascular disorders. The second patent is for "Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use." Similar to the first, it discusses novel substituted compounds aimed at addressing cardiovascular issues through the development of medicaments.
Career Highlights: Markus is associated with Bayer Pharma Aktiengesellschaft, a leading pharmaceutical company known for its emphasis on research and development in the health sector. His work in this esteemed company has facilitated advancements in medical treatments and has solidified his role as a key contributor to innovations in the pharmaceutical industry.
Collaborations: In his professional journey, Markus has collaborated with accomplished coworkers, including Alexandros Vakalopoulos and Ingo Hartung. Their combined expertise enhances the innovative capabilities within their projects, driving forward-thinking solutions in the medical field.
Conclusion: As an inventor, Markus Follman exemplifies the spirit of innovation, particularly in the realm of cardiovascular treatments. His two patents highlight his commitment to creating impactful solutions that can improve patient outcomes. With continued collaboration and research, Follman is poised to contribute even more to the landscape of medical inventions.